Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Retrospective analysis of 119 Chinese noninflammatory locally advanced breast cancer cases treated with intravenous combination of vinorelbine and epirubicin as a neoadjuvant chemotherapy: a median follow-up of 63.4 months

Figure 1

Cumulative Disease-Free Survival. Kaplan-Meier survival estimates according to pathological response in tumor site Abbreviations: T-A, no tumor cell or presence of in situ carcinoma, no invasive tumor; T-B, presence of invasive carcinoma without special involvement (such as skin, vessel, more than one quadrant); T-C, presence of invasive carcinoma with special involvement; Sig, significance. *Table within the figure was the log-rank P value between two curves.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us